Our global site's capabilities align with late-stage therapeutic unit needs and can mitigate potential development risks. Our project management and data services teams will add value to your clinical development process with their expertise in clinical program and trial design. In addition to recognizing these potential risk scenarios, our team will also provide consulting services that will set your asset up for success.
With more than 35 years of experience, our highly skilled team has the capabilities to lead your molecule through a more efficient end-to-end journey.
In addition to our clinical research units (CRUs), we also have a network of 12 U.S. and 17 global Phase I research sites, providing access to healthy volunteers, patients and specialty populations.
